相关实验视频

Updated: Jun 3, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

[BTLA/HVEM轴在血液学和免疫向治疗前景中的表达]

Xiaowan Li¹, Li Zhang¹, Zuxi Feng¹

¹Department of Hematology, Lanzhou University Second Hospital, Lanzhou 730000, China.

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

|January 12, 2025

概括

B和T淋巴细胞减弱器 (BTLA) 和疹病毒入口媒介器 (HVEM) 轴调节免疫平衡,但在癌症中通常是失调的. 针对这一轴为新型癌症免疫疗法提供了一个有希望的途径.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

B和T淋巴细胞减弱剂 (BTLA) 是一种抑制性免疫检查点,与疹病毒入口介质 (HVEM) 相互作用.
在维持免疫耐受性和调节免疫细胞功能方面,BTLA/HVEM相互作用至关重要.
BTLA/HVEM轴的调节失调会损害T细胞功能,促进瘤免疫逃脱和进展.

研究的目的:

审查BTLA和HVEM的分子结构和免疫调节机制.
总结最近在血液恶性瘤中理解BTLA/HVEM轴的进展.
探索潜在的抑制剂和针对BTLA/HVEM相互作用的免疫治疗应用.

主要方法:

对BTLA,HVEM及其在癌症中的作用研究的文献综述.
分子结构和相互作用机制的分析.
在血液恶性瘤和免疫治疗中对BTLA/HVEM进行当前研究的综合.

主要成果:

在各种瘤中,BTLA和HVEM呈现异常表达,与患者的预后相关.
在瘤微环境中,BTLA/HVEM轴在免疫抑制中发挥着重要作用.
准BTLA/HVEM相互作用是增强抗瘤免疫力的潜在策略.

结论:

BTLA/HVEM轴是免疫反应的关键调节者,对癌症的发展有影响.
理解BTLA/HVEM分子相互作用对于开发有效的免疫疗法至关重要.
针对BTLA/HVEM相互作用对治疗血液性恶性瘤有希望.

更多相关视频

Murine Model of CD40-activation of B cells

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Hematopoiesis

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...